| Code | 3088B | ||||||||||
| MA number | 68/0398/14-S | ||||||||||
| Product Form: | tbl plg 6x50 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.02.2015 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Quetiapine Accord 50mg tbl plg_09_2024.pdf
|
| PIL: |
PIL_Quetiapine Accord 50,200,300,400mg tbl plg_09_2024.pdf
|
| Dokument: |
Quetiapine Accord_Prirucka pre zdravotnickych pracovnikov.pdf
|
| Safety feature | Yes |
| Data update: | 24.08.2022 |
